Informations:
Erreur:
ID
25103
Description
A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT00823771
Lien
https://clinicaltrials.gov/show/NCT00823771
Mots-clés
Versions (1)
- 25/08/2017 25/08/2017 -
Téléchargé le
25 août 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Prostate Cancer NCT00823771
Eligibility Prostate Cancer NCT00823771
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT00823771
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Prostate carcinoma TNM clinical staging | Therapeutic radiology procedure Radical Curative
Item
men with a tumour t1-3 stage prostate cancer and have had radical radiotherapy with curative intent
boolean
C0600139 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0439807 (UMLS CUI [2,2])
C1276305 (UMLS CUI [2,3])
C3258246 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0439807 (UMLS CUI [2,2])
C1276305 (UMLS CUI [2,3])
Treatment completion Status post
Item
are between six and twelve months post-treatment completion
boolean
C0580352 (UMLS CUI [1,1])
C0231290 (UMLS CUI [1,2])
C0231290 (UMLS CUI [1,2])
Treatment completed Prostate carcinoma | Antiandrogen therapy completed
Item
have completed all treatment for prostate cancer (including hormonal deprivation therapy)
boolean
C0580352 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0279492 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
C0600139 (UMLS CUI [1,2])
C0279492 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
Neoplasm Metastasis Absent
Item
have no evidence of metastatic disease
boolean
C0027627 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,2])
ECOG performance status
Item
ecog performance status of between 0-1
boolean
C1520224 (UMLS CUI [1])
Protocol Compliance
Item
remains willing to comply with study requirements
boolean
C0525058 (UMLS CUI [1])
Contact with General Practitioner
Item
has maintained contact with an individual general practitioner
boolean
C0332158 (UMLS CUI [1,1])
C0017319 (UMLS CUI [1,2])
C0017319 (UMLS CUI [1,2])
Complications persistent Due to Therapeutic procedure | Toxicity CTCAE Grades
Item
persistent complications resulting from treatment defined as a minimum grade 3 treatment toxicity
boolean
C0009566 (UMLS CUI [1,1])
C0205322 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C0600688 (UMLS CUI [2,1])
C1516728 (UMLS CUI [2,2])
C0205322 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C0600688 (UMLS CUI [2,1])
C1516728 (UMLS CUI [2,2])
Questionnaire Administration Completion Unable
Item
unable to complete self-administered questionnaires
boolean
C1882515 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Study Subject Participation Status Requirement Specialist follow-up
Item
are currently enrolled in a study that requires specialist follow-up
boolean
C2348568 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C2348234 (UMLS CUI [1,3])
C1522577 (UMLS CUI [1,4])
C1514873 (UMLS CUI [1,2])
C2348234 (UMLS CUI [1,3])
C1522577 (UMLS CUI [1,4])
Life Expectancy
Item
life expectancy of less than 6 months
boolean
C0023671 (UMLS CUI [1])
Prostatectomy
Item
surgery to remove the prostate
boolean
C0033573 (UMLS CUI [1])
Failure Biochemical
Item
evidence of biochemical failure
boolean
C0231174 (UMLS CUI [1,1])
C0205474 (UMLS CUI [1,2])
C0205474 (UMLS CUI [1,2])